Unlock the potential behind knowledge laden in clinical articles based on our advanced metadata analysis. From understanding treatment efficacy to predicting disease progression, our comprehensive model provides the insights to drive innovation and optimize therapeutic strategies in drug discovery.
Digital Asset for Clinical Research Metadata Model version 1.0
| Attribute | Description | Data Type | Example Values |
|---|---|---|---|
| StudyDesign | Methodology and type of study | Text | Observational, Randomized Controlled Trial |
| DiseaseState | Condition or disease being studied | Text | Diabetes, Heart Disease |
| Treatment | Treatment(s) under investigation including controls | Text | Drug A, Surgical Procedure B |
| TreatmentGroup | How patients are grouped based on treatment received | Text | Drug A vs. Placebo, Pre-op vs. Post-op |
| Gender | Breakdown of study participants by gender | Categorical | Male, Female, Other |
| Dosage | Dosages of treatment(s) administered | Text | 50mg daily, 100mg twice daily |
| SubjectPopulation | Characteristics of the study population | Text | Ages 18-65, diverse ethnicities |
| Comorbidities | Other medical conditions present in the study population | Text | Hypertension, Obesity |
| HealthcareUtilization | Use of healthcare services during the study | Text | Number of hospital visits, medication use |
| SocioeconomicFactors | Socioeconomic data relevant to the population | Text | Income level, Education level |
| TreatmentPatterns | Real-world use of treatments, including combinations | Text | Sequential use of Drug A then B |
| DrugInteractions | Known or observed interactions between treatments and other medications | Text | Drug A interacts with Drug B |
| CostEffectiveness | Treatment cost in relation to its effectiveness | Text | Cost per QALY, direct and indirect costs |
| GenomicBiomarkerData | Genomic information or biomarkers used for treatment response | Text | Presence of Biomarker X |
| DiseaseProgression | Progression of the disease in the study population | Text | Stages of disease progression |
| EnvironmentalLifestyleFactors | Lifestyle factors impacting health | Text | Diet, Physical activity levels |
| PatientSatisfactionPreferences | Findings on patient satisfaction or care preferences | Text | Satisfaction scores, treatment preference |
| CochraneRiskOfBiasScore | The Cochrane Collaboration’s tool for assessing risk of bias in the results of the study | Score (0-7) | Low, High, Unclear |
| NewcastleOttawaScale | A star system used to judge the quality of non-randomized studies based on three broad perspectives: the selection of the study groups; the comparability of the groups; and the ascertainment of either the exposure or outcome of interest for case-control or cohort studies respectively. | Score (0-9) | 5 stars, 7 stars |